GAD1 and type 1 diabetes mellitus: However, both reported cases [8,9] were positive for anti-GAD antibody at the time of diagnosis of nivolumab-induced type 1 diabetes, suggesting acute exacerbation of slowly progressive insulin-dependent (type 1) diabetes mellitus by nivolumab treatment.